Pluristyx Featured in Labroots webinar

February 27, 2019

Prepare for success: GMP cell banks as part of a staged, standardized, platform-style cell production process

​

Dr. Ben Fryer, Co-Founder and CEO of Pluristyx, presented to webinar participants the “how and why” of integrating high quality ancillary raw materials into cell therapy product development and the manufacturing workflow, beginning with the starting cell source and MCB.